Literature DB >> 10412374

Enteropathogenic Escherichia coli: a pathogen that inserts its own receptor into host cells.

R DeVinney1, A Gauthier, A Abe, B B Finlay.   

Abstract

Enteropathogenic Escherichia coli (EPEC) is a major cause of infant diarrhea, killing hundreds of thousands of children per year worldwide. Intimate attachment to the host cell leading to the formation of actin-rich pedestals beneath the adhering bacteria is an essential feature of EPEC pathogenesis. EPEC attaches to host cells via the outer membrane adhesin, intimin. It was recently shown that EPEC inserts its own receptor for intimate adherence, Tir (translocated intimin receptor) into the host cell membrane. The focus of this review is on the discovery and characterization of this novel receptor, and our current understanding of its role in pedestal formation. Gram-negative bacterial secretion systems, including type III secretion systems, are reviewed and discussed in the context of Tir delivery into the host cell membrane. The relationship and relevance of in vitro models compared to the actual in vivo situation is essential to understanding disease. We have critically reviewed the use of animal models in studying EPEC infection. Elucidating the function of Tir will contribute to our understanding of how EPEC mediates disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10412374     DOI: 10.1007/pl00013202

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  25 in total

1.  Transcriptional regulation of the orf19 gene and the tir-cesT-eae operon of enteropathogenic Escherichia coli.

Authors:  C Sánchez-SanMartín; V H Bustamante; E Calva; J L Puente
Journal:  J Bacteriol       Date:  2001-05       Impact factor: 3.490

2.  Enteropathogenic Escherichia coli mediates antiphagocytosis through the inhibition of PI 3-kinase-dependent pathways.

Authors:  J Celli; M Olivier; B B Finlay
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

3.  Mechanical fractionation reveals structural requirements for enteropathogenic Escherichia coli Tir insertion into host membranes.

Authors:  A Gauthier; M de Grado; B B Finlay
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

4.  Supermolecular structure of the enteropathogenic Escherichia coli type III secretion system and its direct interaction with the EspA-sheath-like structure.

Authors:  K Sekiya; M Ohishi; T Ogino; K Tamano; C Sasakawa; A Abe
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-18       Impact factor: 11.205

5.  Enteropathogenic Escherichia coli activates the RhoA signaling pathway via the stimulation of GEF-H1.

Authors:  Takeshi Matsuzawa; Asaomi Kuwae; Sei Yoshida; Chihiro Sasakawa; Akio Abe
Journal:  EMBO J       Date:  2004-08-19       Impact factor: 11.598

6.  Comparative prevalence of Escherichia coli carrying virulence genes and class 1 and 2 integrons in sub-tropical and cool temperate freshwater.

Authors:  Jatinder P S Sidhu; Paul Jagals; Amy Smith; Simon Toze
Journal:  Environ Sci Pollut Res Int       Date:  2017-06-21       Impact factor: 4.223

7.  Role of EspA and intimin in expression of proinflammatory cytokines from enterocytes and lymphocytes by rabbit enteropathogenic Escherichia coli-infected rabbits.

Authors:  Karina Ramirez; Rocio Huerta; Eric Oswald; Carlos Garcia-Tovar; Jose Manuel Hernandez; Fernando Navarro-Garcia
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

8.  Efficient translocation of EspC into epithelial cells depends on enteropathogenic Escherichia coli and host cell contact.

Authors:  Jorge E Vidal; Fernando Navarro-García
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

9.  Signals, regulatory networks, and materials that build and break bacterial biofilms.

Authors:  Ece Karatan; Paula Watnick
Journal:  Microbiol Mol Biol Rev       Date:  2009-06       Impact factor: 11.056

10.  Lactoferrin impairs type III secretory system function in enteropathogenic Escherichia coli.

Authors:  Theresa J Ochoa; Marita Noguera-Obenza; Frank Ebel; Carlos A Guzman; Henry F Gomez; Thomas G Cleary
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.